Teo, Koon

Optimal Medical Therapy with or without PCI for Stable Coronary Disease

Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., et al. (2007) · New England Journal of Medicine

Coronary Interventions and DiagnosticsAntiplatelet Therapy and Cardiovascular Diseases

Cited by 4,699

Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

Yusuf, S., Joseph, P., Rangarajan, S., Islam, S., Mente, A., Hystad, P., Brauer, M., Kutty, V. R., Gupta, R., Wielgosz, A., et al. (2020) · The Lancet

Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention

Cited by 2,017

Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study

Leong, D. P., Teo, K. K., Rangarajan, S., Lopez-Jaramillo, P., Avezum, A., Orlandini, A., Seron, P., Ahmed, S. H., Rosengren, A., Kelishadi, R., et al. (2015) · The Lancet

Nutrition and Health in AgingFrailty in Older Adults

Cited by 1,876

The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study

Lear, S. A., Hu, W., Rangarajan, S., Gasevic, D., Leong, D., Iqbal, R., Casanova, A., Swaminathan, S., Anjana, R. M., Kumar, R., et al. (2017) · The Lancet

Physical Activity and HealthCardiovascular Health and Risk Factors

Cited by 1,331

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

Rahimi, K., Bidel, Z., Nazarzadeh, M., Copland, E., Canoy, D., Ramakrishnan, R., Pinho-Gomes, A.-C., Woodward, M., Adler, A., Agodoa, L., et al. (2021) · The Lancet

Blood Pressure and Hypertension StudiesSodium Intake and Health

Cited by 1,074

Cardiovascular risk and events in 17 low-, middle-, and high-income countries

Yusuf, S., Rangarajan, S., Teo, K., Islam, S., Li, W., Liu, L., Bo, J., Lou, Q., Lu, F., Liu, T., et al. (2014) · New England Journal of Medicine

Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention

Cited by 983

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE study): a prospective epidemiological survey

Yusuf, S., Islam, S., Chow, C. K., Rangarajan, S., Dagenais, G., Diaz, R., Gupta, R., Kelishadi, R., Iqbal, R., Avezum, A., et al. (2011) · The Lancet

Cardiovascular Health and Risk FactorsLipoproteins and Cardiovascular Health

Cited by 964

Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events

O'Donnell, M., Mente, A., Rangarajan, S., McQueen, M. J., Wang, X., Liu, L., Yan, H., Lee, S. F., Mony, P., Devanath, A., et al. (2014) · New England Journal of Medicine

Sodium Intake and HealthBlood Pressure and Hypertension Studies

Cited by 886

Association of Urinary Sodium and Potassium Excretion with Blood Pressure

Mente, A., O'Donnell, M. J., Rangarajan, S., McQueen, M. J., Poirier, P., Wielgosz, A., Morrison, H., Li, W., Wang, X., Di, C., et al. (2014) · New England Journal of Medicine

Sodium Intake and HealthBlood Pressure and Hypertension Studies

Cited by 858

Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial

Chan, K. L., Teo, K., Dumesnil, J. G., Ni, A., & Tam, J. (2010) · Circulation

Cardiac Valve Diseases and TreatmentsLipoproteins and Cardiovascular Health

Cited by 815

Effects of Ramipril and Vitamin E on Atherosclerosis: The Study to Evaluate Carotid Ultrasound Changes in Patients Treated With Ramipril and Vitamin E (SECURE)

Lonn, E. M., Yusuf, S., Dzavik, V., Doris, C. I., Yi, Q., Smith, S., Moore-Cox, A., Bosch, J., Riley, W. A., & Teo, K. K. (2001) · Circulation

Cardiovascular Health and Disease PreventionRenin-Angiotensin System Studies

Cited by 712

Urinary sodium and potassium excretion and risk of cardiovascular events

O'Donnell, M. J., Yusuf, S., Mente, A., Gao, P., Mann, J. F., Teo, K., McQueen, M., Sleight, P., Sharma, A. M., Dans, A., et al. (2011) · JAMA

Sodium Intake and HealthBlood Pressure and Hypertension Studies

Cited by 564

Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies

Mente, A., O'Donnell, M., Rangarajan, S., Dagenais, G., Lear, S., McQueen, M., Diaz, R., Avezum, A., Lopez-Jaramillo, P., Lanas, F., et al. (2016) · The Lancet

Sodium Intake and HealthBlood Pressure and Hypertension Studies

Cited by 483

Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis

Capoulade, R., Chan, K. L., Yeang, C., Mathieu, P., Bossé, Y., Dumesnil, J. G., Tam, J. W., Teo, K. K., Mahmut, A., Yang, X., et al. (2015) · Journal of the American College of Cardiology

Cardiac Valve Diseases and TreatmentsAtherosclerosis and Cardiovascular Diseases

Cited by 417

Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116 632 people from 21 countries

Wang, C., Bangdiwala, S. I., Rangarajan, S., Lear, S. A., AlHabib, K. F., Mohan, V., Teo, K., Poirier, P., TSE, L. A., Liu, Z., et al. (2019) · European Heart Journal

Sleep and related disordersSleep and Work-Related Fatigue

Cited by 385

Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study

Mente, A., O'Donnell, M., Rangarajan, S., McQueen, M., Dagenais, G., Wielgosz, A., Lear, S., Ah, S. T. L., Wei, L., Diaz, R., et al. (2018) · The Lancet

Sodium Intake and HealthBlood Pressure and Hypertension Studies

Cited by 332

Effects of exercise training in patients with heart failure: The Exercise Rehabilitation Trial (EXERT)

McKelvie, R. S., Teo, K. K., Roberts, R., McCartney, N., Humen, D., Montague, T., Hendrican, K., & Yusuf, S. (2002) · American Heart Journal

Cardiovascular and exercise physiologyCardiac Health and Mental Health

Cited by 322

Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials

Böhm, M., Schumacher, H., Teo, K. K., Lonn, E. M., Mahfoud, F., Mann, J. F. E., Mancia, G., Redon, J., Schmieder, R. E., Sliwa, K., et al. (2017) · The Lancet

Blood Pressure and Hypertension StudiesRenin-Angiotensin System Studies

Cited by 315

Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries: The Prospective Urban Rural Epidemiology (PURE) Study

Teo, K., Lear, S., Islam, S., Mony, P., Dehghan, M., Li, W., Rosengren, A., Lopez-Jaramillo, P., Diaz, R., Oliveira, G., et al. (2013) · JAMA

Cardiovascular Health and Risk FactorsHealth and Lifestyle Studies

Cited by 305

Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study

Smyth, A., Teo, K. K., Rangarajan, S., O'Donnell, M., Zhang, X., Rana, P., Leong, D. P., Dagenais, G., Seron, P., Rosengren, A., et al. (2015) · The Lancet

Alcohol Consumption and Health EffectsSubstance Abuse Treatment and Outcomes

Cited by 230

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies

Anderson, C., Teo, K., Gao, P., Arima, H., Dans, A., Unger, T., Commerford, P., Dyal, L., Schumacher, H., Pogue, J., et al. (2011) · The Lancet Neurology

Renin-Angiotensin System StudiesDementia and Cognitive Impairment Research

Cited by 216

Early cerebral small vessel disease and brain volume, cognition, and gait

Smith, E. E., O'Donnell, M., Dagenais, G., Lear, S. A., Wielgosz, A., Sharma, M., Poirier, P., Stotts, G., Black, S. E., Strother, S., et al. (2015) · Annals of Neurology

Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research

Cited by 207

The Polypill in the Prevention of Cardiovascular Diseases: Key Concepts, Current Status, Challenges, and Future Directions

Lonn, E., Bosch, J., Teo, K. K., Pais, P., Xavier, D., & Yusuf, S. (2010) · Circulation

Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention

Cited by 174

Environmental and societal influences acting on cardiovascular risk factors and disease at a population level: a review

Chow, C. K., Lock, K., Teo, K., Subramanian, S., McKee, M., & Yusuf, S. (2009) · International Journal of Epidemiology

Cardiovascular Health and Risk FactorsHealthcare Systems and Public Health

Cited by 160